Total Payments
$29,545
2024 Payments
$6,839
Companies
41
Transactions
1,041
Medicare Patients
2,287
Medicare Billing
$2.9M
Payment Breakdown by Category
Food & Beverage$19,043 (64.5%)
Consulting$7,615 (25.8%)
Other$2,460 (8.3%)
Travel$227.80 (0.8%)
Education$198.64 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,043 | 1,024 | 64.5% |
| Consulting Fee | $7,615 | 6 | 25.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,660 | 2 | 5.6% |
| Honoraria | $800.00 | 1 | 2.7% |
| Travel and Lodging | $227.80 | 1 | 0.8% |
| Education | $198.64 | 7 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $7,524 | 216 | $0 (2024) |
| UCB, Inc. | $4,499 | 108 | $0 (2024) |
| ABBVIE INC. | $4,232 | 175 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,878 | 51 | $0 (2024) |
| Amgen Inc. | $2,593 | 147 | $0 (2024) |
| Horizon Therapeutics plc | $1,333 | 50 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $925.33 | 37 | $0 (2024) |
| Lilly USA, LLC | $868.60 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $808.75 | 32 | $0 (2024) |
| PFIZER INC. | $428.28 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,839 | 222 | UCB, Inc. ($2,452) |
| 2023 | $5,755 | 244 | Janssen Biotech, Inc. ($1,706) |
| 2022 | $4,908 | 267 | Janssen Biotech, Inc. ($907.83) |
| 2021 | $12,042 | 308 | Janssen Biotech, Inc. ($3,861) |
All Payment Transactions
1,041 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Organon Llc | HADLIMA (Drug), RENFLEXIS | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: OSTEOPOROSIS | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Immunology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Bone Health | ||||||
| 11/12/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 402 | 43,675 | $2.2M | $753,807 |
| 2022 | 13 | 478 | 26,578 | $1.7M | $621,933 |
| 2021 | 17 | 717 | 36,880 | $1.9M | $773,601 |
| 2020 | 17 | 690 | 23,060 | $1.7M | $766,995 |
Total Patients
2,287
Total Services
130,193
Medicare Billing
$2.9M
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 16 | 12,375 | $1.2M | $415,989 | 33.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 14 | 13,435 | $470,225 | $135,688 | 28.9% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 12 | 13,650 | $242,970 | $108,725 | 44.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 31 | 3,181 | $95,340 | $58,108 | 60.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 241 | $44,001 | $17,496 | 39.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 34 | 234 | $27,703 | $9,267 | 33.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 27 | $5,724 | $2,391 | 41.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 49 | 254 | $9,398 | $2,272 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,352 | $1,358 | 31.2% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 22 | 22 | $5,500 | $861.73 | 15.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 16 | $2,599 | $672.17 | 25.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 20 | 20 | $5,000 | $598.20 | 12.0% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 17 | 83 | $1,660 | $329.65 | 19.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 13 | 120 | $720.00 | $51.75 | 7.2% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 20 | 12,000 | $1.2M | $408,546 | 34.0% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 13 | 10,050 | $351,750 | $116,467 | 33.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 37 | 3,600 | $90,000 | $60,087 | 66.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 246 | $38,622 | $17,098 | 44.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 39 | 224 | $25,760 | $9,400 | 36.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 32 | $6,784 | $3,480 | 51.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $7,712 | $2,151 | 27.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 54 | 185 | $6,845 | $1,671 | 24.4% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2022 | 36 | 36 | $9,000 | $1,439 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 22 | $2,354 | $1,023 | 43.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 16 | 16 | $4,000 | $472.24 | 11.8% |
About Iris Zink, NP
Iris Zink, NP is a Family healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487729752.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Iris Zink, NP has received a total of $29,545 in payments from pharmaceutical and medical device companies, with $6,839 received in 2024. These payments were reported across 1,041 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($19,043).
As a Medicare-enrolled provider, Zink has provided services to 2,287 Medicare beneficiaries, totaling 130,193 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Lansing, MI
- Active Since 11/22/2006
- Last Updated 08/21/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1487729752
Products in Payments
- TREMFYA (Drug) $7,240
- ORENCIA (Biological) $2,504
- Cimzia (Drug) $1,990
- RINVOQ (Biological) $1,621
- KRYSTEXXA (Biological) $1,148
- Enbrel (Biological) $1,145
- SAPHNELO (Biological) $887.10
- TALTZ (Drug) $707.28
- SKYRIZI (Biological) $672.39
- COSENTYX (Drug) $533.75
- XELJANZ (Drug) $409.91
- BENLYSTA (Biological) $381.74
- Briviact (Drug) $338.95
- AMJEVITA (Biological) $331.46
- REMICADE (Biological) $330.21
- EVENITY (Biological) $313.21
- OFEV (Drug) $305.46
- COSENTYX (Biological) $257.31
- SIMPONI ARIA (Biological) $244.06
- PURIFIED CORTROPHIN GEL (Drug) $242.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lansing
Carissa Camp, Np-C, NP-C
Family — Payments: $7,232
Family $7,232
Rebeccah Freel, Fnp-C, FNP-C
Family — Payments: $6,770
Family $6,770
Kristal Richardson-Aubrey, Np-C, NP-C
Family — Payments: $5,600
Family $5,600
Mrs. Carol Salisbury, Cnp, CNP
Family — Payments: $5,593
Family $5,593
Whitney Beam, Fnp-C, FNP-C
Family — Payments: $5,388
Family $5,388
Jaimie Fast, Arnp, ARNP
Family — Payments: $5,033
Family $5,033